EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine.
Recruiting now
Conditions studied: Migraine Disorders
In brief
The object of this study is to assess the effectiveness, safety, and tolerability of eptinezumab in a real life migraine population.
Key facts
- Study ID
- NCT05570149
- Run by
- IRCCS San Raffaele Roma
- People needed
- 500
- Starts
- 2023-01-01
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2025-05-01
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- IRCCS San Raffaele Roma — Roma, RM, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.